featured
2022 Top Story in Oncology: DESTINY-Breast04 — Trastuzumab Deruxtecan for HER2-Low Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: